In vitro diagnostics outfit BacterioScan closed an oversubscribed Series A financing round to support development of its next-generation, rapid diagnostic test for urinary tract infection (UTI). The ...
The way we diagnose urinary tract infections is still pretty belabored. The most common method is examining a urine sample for errant bacteria or blood cells. Other methods include a urine sample and ...
In this handout photo, a gloved hand loading a clinical sample into the BacterioScan Inc. instrument's disposable sample container. The BacterioScan Inc. instrument (Model 216 Dx) is shown in the ...
Creating a quicker, cheaper and more accurate way for doctors to test patients for urinary tract infections has netted a St. Louis startup at least $2 million in its latest round of fundraising.
ST. LOUIS, Oct. 3, 2019 /PRNewswire/ -- BacterioScan, Inc., a St. Louis-based rapid diagnostic device company, has been selected to present advances on its in vitro diagnostic platform at IDWeek 2019.
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. BioSTL logo BioSTL's nonprofit investment arm has joined in the latest round of funding for diagnostic startup BacterioScan. The ...